SABRIL (vigabatrin) is a prescription medicine utilized with other therapies in grownups and youngsters 2 years of age and older with refractory complicated partial seizures (CPS) that have not responded well enough to numerous other therapies and if the possible advantages exceed the threat of vision loss.
It is recommended that your doctor test your (or your youngster's) vision prior to or within 4 weeks after starting SABRIL and at the very least every 3 months during therapy until SABRIL is quit. If you or your youngster have any side effect that troubles you or that does not go away, inform your medical care carrier.
If seizures get even worse, tell your healthcare company right away. You and your healthcare provider will have to make a decision if you need to take SABRIL while you are pregnant. One of the most common adverse effects of SABRIL in grownups include: obscured vision, drowsiness, dizziness, problems walking or feeling unskillful, drinking (trembling), and fatigue.